Original Research
Published on 13 Aug 2019
Astragaloside III Enhances Anti-Tumor Response of NK Cells by Elevating NKG2D and IFN-Îł
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00898
- 8,360 views
- 41 citations
